The goals of this application are the dissection of the relative functional role of the major outer membrane protein (MOMP) variant sequence (VS) regions and CAL as immune targets of antibody mediated neutralization, and the evaluation of the human humoral response of trachoma tear samples to sequence-specific chlamydial epitopes and correlation of this data to neutralization capability and clinical status. The broad, long-term objectives are development of a basic understanding of immune mechanisms elicited during natural infection for developing and evaluating strategies for immune prophylactic intervention.
The specific aims are: 1) Characterize the antigenicity and immunogenicity of CAL. Antigenicity of CAL will be tested using natural CAL purified from chlamydia infected tissue cultures and probed using human immune sera. Antigenic specificity will be investigated using monoclonal antibodies produced to CAL. Immunogenicity of native CAL will be evaluated by immunization of animals and tested by neutralization. The mechanism and efficacy of neutralization by anti-CAL antibodies will be compared to anti-MOMP antibodies. 2) Systematically characterize the humoral immune responses to Chlamydia trachomatis infection. The focus is comparison of humoral responses evaluated by MOMP-sequence defined immunoassay with special emphasis on the functional role of antibodies to defined MOMP regions using an in vitro infectivity neutralization assay to dissect efficacious neutralization targets. 3) Determine the tear antibody repertoire specificities to chlamydial antigens and tear antibody functional capabilities in neutralization. Antibodies in tears from trachoma patients will be evaluated for IgG and IgA (sIgA) and their quantity, epitopic specificities and neutralization abilities determined. Evaluate the relationship of tear antibody specificity, Ig class, and function with infection status and infecting strain.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
2R01EY007757-06
Application #
2161688
Study Section
Bacteriology and Mycology Subcommittee 2 (BM)
Project Start
1988-08-01
Project End
1999-03-31
Budget Start
1994-04-01
Budget End
1995-03-31
Support Year
6
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
Organized Research Units
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Grimwood, J; Olinger, L; Stephens, R S (2001) Expression of Chlamydia pneumoniae polymorphic membrane protein family genes. Infect Immun 69:2383-9
Bain, D L; Lietman, T; Rasmussen, S et al. (2001) Chlamydial genovar distribution after community wide antibiotic treatment. J Infect Dis 184:1581-8
Stephens, R S; Koshiyama, K; Lewis, E et al. (2001) Heparin-binding outer membrane protein of chlamydiae. Mol Microbiol 40:691-9
Rasmussen-Lathrop, S J; Koshiyama, K; Phillips, N et al. (2000) Chlamydia-dependent biosynthesis of a heparan sulphate-like compound in eukaryotic cells. Cell Microbiol 2:137-44
Stephens, R S; Fawaz, F S; Kennedy, K A et al. (2000) Eukaryotic cell uptake of heparin-coated microspheres: a model of host cell invasion by Chlamydia trachomatis. Infect Immun 68:1080-5
Jones, H M; Kubo, A; Stephens, R S (2000) Design, expression and functional characterization of a synthetic gene encoding the Chlamydia trachomatis major outer membrane protein. Gene 258:173-81
Ellen, J M; Lammel, C J; Shafer, M A et al. (1999) Cervical secretory immunoglobulin A in adolescent girls. J Adolesc Health 25:150-4
Tomarev, S I; Tamm, E R; Chang, B (1998) Characterization of the mouse Myoc/Tigr gene. Biochem Biophys Res Commun 245:887-93
Tomarev, S I; Zinovieva, R D; Chang, B et al. (1998) Characterization of the mouse Prox1 gene. Biochem Biophys Res Commun 248:684-9
Chen, J C; Stephens, R S (1997) Chlamydia trachomatis glycosaminoglycan-dependent and independent attachment to eukaryotic cells. Microb Pathog 22:23-30

Showing the most recent 10 out of 31 publications